Abstract
Current approaches to treatment of Helicobacter pylori infection, basic international recommendations, problems of growing H. pylori resistance to antibiotics are reviewed. Much attention is given to prospects of new eradication schemes, for example combinations based on bismuth tripotassium dicitrate and successive treatment schedules.
MeSH terms
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / adverse effects
-
Anti-Infective Agents / therapeutic use*
-
Drug Resistance, Multiple, Bacterial
-
Drug Therapy, Combination
-
Helicobacter Infections / drug therapy*
-
Helicobacter Infections / microbiology
-
Helicobacter pylori / drug effects*
-
Helicobacter pylori / isolation & purification
-
Humans
-
Metronidazole / administration & dosage
-
Metronidazole / adverse effects
-
Metronidazole / therapeutic use
-
Organometallic Compounds / administration & dosage
-
Organometallic Compounds / adverse effects
-
Organometallic Compounds / therapeutic use*
-
Proton Pump Inhibitors / administration & dosage
-
Proton Pump Inhibitors / adverse effects
-
Proton Pump Inhibitors / therapeutic use*
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Organometallic Compounds
-
Proton Pump Inhibitors
-
Metronidazole
-
bismuth tripotassium dicitrate